Food and Drug Administration Regulations; Change of Addresses; Technical Amendment

Information

Type

Rule

Regulated products

Published

April 3, 2015

Last updated

April 3, 2015

Description

Document number 2015-07268. The Food and Drug Administration (FDA) is amending its regulations to update address information for the Center for Biologics Evaluation and Research (CBER) as a result of the recent relocation of CBER offices and laboratories to the FDA White Oak campus in Silver Spring, MD, as well as make other related technical revisions. These changes are being made to ensure the accuracy of the Agency's regulations.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed